Tuesday, December 2, 2008 - 4:54PM EST

General Interest Articles

1. Osteoporosis in men: pathophysiology and treatment.

Author
Gennari L; Bilezikian JP;
Institution
College of Physicians and Surgeons, 630 W. 168th Street, New York, NY 10032, USA.
Journal
Curr Osteoporos Rep. 2007 Mar;5(1):22-8.
Abstract URL
Click here to view abstract

2. Monitoring osteoporosis therapies.

Author
Miller PD;
Institution
Colorado Center for Bone Research, 3190 S. Wadsworth Boulevard, Suite 250, Lakewood, CO 80227, USA. millerccbr@aol.com
Journal
Curr Osteoporos Rep. 2007 Mar;5(1):38-43.
Abstract URL
Click here to view abstract

3. Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects.

Author
Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY;
Institution
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Department of Public Health, Epidemiology and Health Economics, University of Liege, 4000 Liege, Belgium. veronique.rabenda@ulg.ac.be
Journal
Aging Clin Exp Res. 2007 Feb;19(1):55-60.
Abstract URL
Click here to view abstract

4. Prevention and treatment of glucocorticoid-induced osteoporosis.

Author
Curtis JR; Saag KG;
Institution
University of Alabama at Birmingham, FOT 840, 510 20th Street South, Birmingham, AL 35294, USA. jcurtis@uab.edu
Journal
Curr Osteoporos Rep. 2007 Mar;5(1):14-21.
Abstract URL
Click here to view abstract

5. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.

Author
Patel R; Blake GM; Fogelman I;
Institution
Academic Bone Densitometry Unit, Imperial College London, Charing Cross Campus, St. Dunstan's Road, London W6 8RP, UK. r.patel@imperial.ac.uk
Journal
Calcif Tissue Int. 2007 Feb;80(2):89-96. Epub 2007 Feb 2.
Abstract URL
Click here to view abstract

6. Prevention of osteoporosis: four-year follow-up of a cohort of postmenopausal women treated with an ossein-hydroxyapatite compound.

Author
Fernandez-Pareja A; Hernandez-Blanco E; Perez-Maceda JM; Riera Rubio VJ; Palazuelos JH; Dalmau JM;
Institution
Centro de Madrid Salud Tetuan, Madrid, Spain. fernandezpan@hotmail.com
Journal
Clin Drug Investig. 2007;27(4):227-32.
Abstract URL
Click here to view abstract

7. Use of quantitative ultrasound scans of the calcaneus to diagnose osteoporosis in patients with rheumatoid arthritis.

Author
Cryer JR; Otter SJ; Bowen CJ; Cryer JR; Otter SJ; Bowen CJ;
Institution
Department of Podiatry, Eastbourne Downs Primary Care Trust, Eastbourne, England.
Journal
J Am Podiatr Med Assoc. 2007 Mar-Apr;97(2):108-14.
Abstract URL
Click here to view abstract

8. Early and rapid bone mineral density loss of the proximal femur in men.

Author
Nordstrom P; Neovius M; Nordstrom A;
Institution
Department of Surgical and Perioperative Sciences, Sports Medicine Unit, Umea University, 901 85 Umea, Sweden. peter.nordstrom@idrott.umu.se
Journal
J Clin Endocrinol Metab. 2007 May;92(5):1902-8. Epub 2007 Feb 20.
Abstract URL
Click here to view abstract

9. Fracture risk with intermittent high-dose oral glucocorticoid therapy.

Author
De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP;
Institution
University of Utrecht, Utrecht, The Netherlands.
Journal
Arthritis Rheum. 2007 Jan;56(1):208-14.
Abstract URL
Click here to view abstract

10. Do inhaled steroids increase the risk of osteoporosis?

Author
Geralyi F; Loven B; Rodriguez JE;
Institution
Johnson City Family Practice Residency, East Tennessee State University, Johnson City, TN USA.
Journal
J Fam Pract. 2007 Feb;56(2):131-6.
Abstract URL
Click here to view abstract
Pages: 1 2 3